Effect of glucosamine on glucose control

Annals of Pharmacotherapy

Volumn 40, Issue 4, 2006, Pages 694-698

  Stumpf, Janice L ^a,b   Lin, Shu Wen ^b,c  

^a Drug Information Service   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Glucosamine; Glucose control

Indexed keywords

GLUCOSAMINE; HEMOGLOBIN A1C; PLACEBO;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SCREENING;

BLOOD GLUCOSE; DATABASES, BIBLIOGRAPHIC; GLUCOSAMINE; GLUCOSE; HUMANS; INSULIN RESISTANCE; OSTEOARTHRITIS;

EID: 33646271384     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E658     Document Type: Review

References (24)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44.
2. Bruno JJ, Ellis JJ. Herbal use among US elderly: 2002 National Health Interview Survey. Ann Pharmacother 2005;39:643-8. Epub 1 Mar 2005. DOI 10.1345/aph.1E460
3. Virkamaki A, Daniels MC, Hamalainen S, Utriainen T, McClain D, Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 1997;138:2501-7.
4. Scroggie DA, Albright A, Harris MD. The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Arch Intern Med 2003;163:1587-90.
5. McClain DA, Crook ED. Hexosamines and insulin resistance. Diabetes 1996;45:1003-9.
6. Monauni T, Zenti MG, Cretti A, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 2000;49:926-35.
7. Pouwels MJ, Jacobs JR, Span PN, Lutterman JA, Smits P, Tack CJ. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab 2001;86:2099-103.
8. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6.
9. Pavelká K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002;162:2113-23.
10. Tannis AJ, Barban J, Conquer JA. Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals. Osteoarthritis Cartilage 2004;12:506-11.
11. Yu JG, Boies SM, Olefsky JM. The effect of oral glucosamine sulfate on insulin sensitivity in human subjects (letter). Diabetes Care 2003;26:1941-2.
12. Almada AL, Harvey PW, Platt KJ. Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in nondiabetic individuals (abstract). FASEB J 2000;14:A750.
13. D'Ambrosio E, Casa B, Bompani R, Scali G, Scali M. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmacotherapeutica 1981;2:504-8.
14. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther 1980;3:260-72.
15. Institute of Medicine and National Research Council of the National Academies. Glucosamine prototype monograph. Dietary supplements: a framework for evaluating safety. 2004. C1-C86. www.iom.edu/Object. File/Master/19/560/0.pdf (accessed 2005 Aug 8).
16. Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol 2005;43:187-201.
17. Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. Arzneimittelforschung 2001;51:699-725.
18. Setnikar I, Pacini MA, Revel L. Antiarthritic effects of glucosamine sulfate studied in animal models. Arzneimittelforschung 1991;41:542-5.
19. Stender S, Astrup P. Glucosamine and experimental atherosclerosis. Increased wet weight and changed composition of cholesterol fatty acids in aorta of rabbits fed a cholesterol-enriched diet with added glucosamine. Atherosclerosis 1977;26:205-13.
20. Echard BW, Talpur NA, Funk KA, Bagchi D, Preuss HG. Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats. Mol Cell Biochem 2001;225:85-91.
21. Yki-Jarvinen H, Daniels MC, Virkamaki A, Makimattila S, DeFronzo RA, McClain D. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes 1996;45:302-7.
22. Daniels MC, Ciaraldi TP, Nikoulina S, Henry RR, McClain DA. Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 1996;97:1235-41.
23. Rovati LC, Annefeld M, Giacovelli G, Schmid K, Setnikar I. Glucosamine in osteoarthritis (letter). Lancet 1999;354:1640.
24. Jain RK, McCormick JC. Can glucosamine supplements be applied for all patients with type 2 diabetes with osteoarthritis (letter)? Arch Intern Med 2004;164:807.